CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nikkiso Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nikkiso Co Ltd
22F, Yebisu Garden Place Tower
4-20-3, Ebisu
Phone: +81 334433711p:+81 334433711 SHIBUYA-KU, TKY  150-6022  Japan Ticker: 63766376
Business Summary
NIKKISO CO.,LTD. is a Japan-based company principally engaged in the manufacture and sale of industrial pumps, precision equipment and blood related products, among others. The Company operates in two business segments. Industrial Business segment conducts industrial business including the manufacture, sale and maintenance of industrial special pumps, as well as liquefied gas & industrial gas related equipment and devices. The Segment is also involved in precision equipment business, aerospace business and deep ultraviolet light emitting diode (LED) business. Medical Business segment’s products are dialysis-related products including hemodialysis and peritoneal dialysis, such as artificial dialysis machines, dialyzers, blood circuits, and powder-type dialysis agents. The Segment also manufactures, sells and maintains products and medicines related to CRRT (acute blood purification therapy), artificial pancreas devices that manage blood glucose, and energy devices for microwave surgery.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes---Yes

Industries
SIC Code Description
3561 Pumps and pumping equipment
3594 Fluid power pumps and motors
3823 Industrial instruments for measurement, display, and control of processes
3679 Electronic components, not elsewhere classified
3826 Laboratory analytical instruments
3624 Carbon and graphite products
3842 Orthopedic, prosthetic, and surgical appliances and supplies
3843 Dental equipment and supplies
3559 Special industry machinery, not elsewhere classified
7389 Business services, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Representative Director ToshihikoKai 75 12/1/2004 6/1/2003
Managing Executive Officer, Chief Director of Industrial Business, Director KoichiKato 52 2/14/2024 3/1/2023
Managing Executive Officer, Chief Director of Medical Business, Director MasaruYamamura 58 2/14/2024 1/1/2018
11 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Geveke NV Gooimeer 6-35 Naarden Netherlands
CRYOTEC Anlagenbau GmbH Dresdener Str. 76 Wurzen Germany
Cryogenic Industries Service Companies 25720 Jefferson Ave Murrieta CA United States
5 additional Subsidiary records available in full report.

Business Names
Business Name
6376
ACD LLC
Atlas Copco JC Carter
13 additional Business Names available in full report.

General Information
Number of Employees: 8,131 (As of 12/31/2023)
Outstanding Shares: 66,250,460 (As of 9/30/2024)
Shareholders: 14,118
Stock Exchange: TYO
Fax Number: +81 334734963


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024